or
forgot password

    • cancer clinical trials in bellingham, WA

    • S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
    St. Joseph Hospital Community Cancer Center
    Bellingham, Washington 98225
    Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    St. Joseph Hospital Community Cancer Center
    Bellingham, Washington 98225
    Pancreatic Cancer
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    St. Joseph Hospital Community Cancer Center
    Bellingham, Washington 98225
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    St. Joseph Hospital Community Cancer Center
    Bellingham, Washington 98225
    Lung Cancer
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Esophageal Cancer
    S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Sarcoma
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Breast Cancer
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Esophageal Cancer
    Community Based Trial for AMEVIVE®
    Dermatology & Laser Center
    Bellingham, Washington 98225
    Moderate to Severe Chronic Plaque Psoriasis
    Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Sarcoma
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    PeaceHealth Saint Joseph Medical Center
    Bellingham, Washington 98225
    Recurrent Melanoma, Stage IV Melanoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    PeaceHealth Saint Joseph Medical Center
    Bellingham, Washington 98225
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
    PeaceHealth Saint Joseph Medical Center
    Bellingham, Washington 98225
    Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Brain and Central Nervous System Tumors
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Head and Neck Cancer
    Assessment and Tracking of Long-term Alefacept Safety
    Dermatology & Laser Center Northwest
    Bellingham, Washington 98225
    Psoriasis
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    PeaceHealth Saint Joseph Medical Center
    Bellingham, Washington 98225
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    S0309, Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    St. Joseph Cancer Center
    Bellingham, Washington 98225
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    PeaceHealth Saint Joseph Medical Center
    Bellingham, Washington 98225
    Light Chain Deposition Disease, Primary Systemic Amyloidosis
    Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
    PeaceHealth Medical Group PC
    Bellingham, Washington 98226
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer